## Analysis of Vitamin A Deficiency in Children **Key Point:** Bitot's spots are characteristic of vitamin A deficiency but are NOT pathognomonic — they can also be seen in other conditions and are not specific to vitamin A deficiency alone. While they are highly suggestive, the term "pathognomonic" (uniquely characteristic) is incorrect. ### Clinical Manifestations of Vitamin A Deficiency | Feature | Details | |---------|----------| | **Night blindness** | First reversible sign; due to impaired rhodopsin synthesis in retinal rods | | **Bitot's spots** | Foamy, triangular patches on temporal conjunctiva; highly suggestive but not pathognomonic | | **Corneal changes** | Xerosis → corneal haze → ulceration → scarring (irreversible if untreated) | | **Conjunctival xerosis** | Drying of conjunctiva; precedes corneal involvement | | **Phthisis bulbi** | End-stage shrunken eye; permanent blindness | **High-Yield:** Vitamin A deficiency is the leading preventable cause of childhood blindness globally, particularly in South Asia and sub-Saharan Africa. ### Systemic Effects Beyond Ocular Manifestations 1. **Immune dysfunction:** Reduced secretory IgA and impaired T-cell mediated immunity 2. **Increased infection susceptibility:** Measles, diarrhea, respiratory infections, malaria 3. **Growth retardation:** Impaired epithelial cell differentiation 4. **Skin changes:** Follicular hyperkeratosis, phrynoderma ("toad skin") **Clinical Pearl:** In children with measles, vitamin A supplementation (200,000 IU for 2 days, then repeat at 2 weeks) reduces mortality by ~23% and morbidity significantly — this is WHO-recommended even in non-deficient populations. **Warning:** Corneal scarring and phthisis bulbi are IRREVERSIBLE complications. Prevention through supplementation (200,000 IU annually in endemic areas) is critical.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.